Navigation Links
Inhaled Insulin Could Rock The Drug Market Soon

Following approval of Exubera, an oral insulin formulation by the U.S. Food and Drug Administration and the European Commission, the sales of the new treatment // modality is expected to soar in the next couple of months. The drug is a combined effort of three major pharmaceutical companies Sanofi-Aventis, Pfizer and Nektar Therapeutics.

The new formulation could eventually save the trouble of daily insulin injections for millions of diabetics worldwide. However, it cannot be viewed as a replacement as it may not be suitable for everyone.

Insulin, secreted by specialized cells of the pancreas plays a vital role in the maintenance of blood sugar levels. Diabetic individuals depend on insulin to maintain a balance. Poor blood sugar control over a prolonged time can lead to cardiovascular disease, kidney failure and stroke. In addition, it can impair the normal blood flow and vision.

Although insulin has been sold since 1920s, this new inhaled insulin form (powder that can be breathed inside using a mouthpiece) represents a major milestone in diabetic treatment. It is contraindicated in current smokers or in those who have stopped smoking for less than six months and patients with lung disease.

Pfizer would study the long-term effects of the new drug formulation shortly. Previous studies have established incidence of mild cough as a consequence of Exubera use. It is therefore recommended that all individuals who take the formulation undergo lung evaluation prior to use, which can be extended to every year following administration.

Apart from the above mentioned treatment regimen, the importance of diet, weight reduction and exercise should not be forgotten.


'"/>




Page: 1

Related medicine news :

1. Inhaled Steroids Safe & Effective for Children with Asthma
2. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
3. The Effectiveness Of Inhaled Corticosteroids Studied
4. The Effectiveness Of Inhaled Corticosteroids Studied
5. Inhaled nitric oxide therapy does not reduce death risk of infants
6. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
7. HIIP- A Novel Inhaled Insulin Delivery System As An Alternative To Injectable Insulin Therapy
8. Inhaled Insulin To Be Made Available in India
9. High Cost Forces NHS To Reject Inhaled Insulin
10. Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients
11. Inhaled Insulin: A New Modality for Management of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... ... May 25, 2016 , ... ... compare outcomes of injured workers across 15 states. The outcomes examined in these ... access to medical care, and satisfaction with medical care. , “The goal of ...
(Date:5/25/2016)... ... , ... Cheryl Bowker of Bowker Insurance Group has been presented with one ... Award. McKenna ran one of Allstate’s most successful agencies for 48 years, but it ... him. The award named for him is not given every year, but only when ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Casa Velas, ... restorative properties of precious stones to complement its new wellness suites . The ... floors and feature a plethora of special services and insuite amenities, from a custom ...
(Date:5/25/2016)... ... 2016 , ... Laser Skin & Wellness Center is excited to ... of female aging. The Juliet™ procedure helps to reverse the effects ... laxity, itchiness and pain have reported real relief from these and other problems by ...
(Date:5/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... of its new DeSoto facility. , “We are pleased to announce Dr. Nguyen ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Nguyen ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... NORTH CHESTERFIELD, Va. , May 25, 2016 ... commercially-available next-generation sequencing test for wounds and infections. ... fungi, ALL parasites, and select viruses. The test ... infected area. David G. ... advanced molecular testing to facilitate wound healing: "We ...
(Date:5/25/2016)... 25, 2016 MedDay, a biotechnology company ... an oral presentation entitled "High doses of biotin in progressive ... be given by Professor Ayman Tourbah , Principal Investigator ... the European Academy of Neurology (EAN) in Copenhagen, ... 3" will take place on Sunday, 29 May 2016 from ...
(Date:5/25/2016)... , May 25, 2016 ... 2016"market research report that provides an overview on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
Breaking Medicine Technology: